drug-manufacturer

3 cases — ← All topics

Case	Title	Lower Court	Docketed	Status	Flags	Tags	Question Presented
24-1302	MSP Recovery Claims, Series LLC, a Delaware Series Limited Liability Company, et al. v. Lundbeck LLC, a Delaware Corporation, et al.	Fourth Circuit	2025-06-26	Denied	Response RequestedResponse WaivedRelisted (2)	civil-rico drug-manufacturer foreseeability prescribing-decisions proximate-cause rico-statute	(1) Whether, in a civil RICO action against a drug manufacturer for overpayment of drugs, physicians' prescribing decisions constitute an intervening …
19-1444	GlaxoSmithKline LLC v. United Food and Commercial Workers Local 1776 and Participating Employers Health and Welfare Fund, et al.	Third Circuit	2020-07-01	Denied	Amici (1)Response Waived	avandia brand-name-drug brand-name-drugs conflict-preemption drug-labeling drug-manufacturer fda-preemption fda-regulations label-change material-information regulatory-compliance tort-claims	Whether federal law preempts state-law tort claims where a brand-name drug's manufacturer provides the FDA with all material information in its posses…
18-803	Wendy B. Dolin v. GlaxoSmithKline, LLC, fka SmithKline Beecham Corporation	Seventh Circuit	2018-12-21	Denied	Relisted (2)	clinical-trials drug-labeling drug-manufacturer fda-regulations impossibility-preemption labeling-changes preemption truthful-risks unilateral-labeling-changes unilateral-warning wyeth-v-levine	Does federal law prevent a drug manufacturer from enhancing its label to reflect truthful risks revealed in its clinical trials when the relevant FDA …